Objective There is a lack of standardisation in the terminology used to describe gout. The aim of this project was to develop a consensus statement describing the recommended nomenclature for disease states of gout. Methods A content analysis of gout-related articles from rheumatology and general internal medicine journals published over a 5-year period identified potential disease states and the labels commonly assigned to them. Based on these findings, experts in gout were invited to participate in a Delphi exercise and face-to-face consensus meeting to reach agreement on disease state labels and definitions. Results The content analysis identified 13 unique disease states and a total of 63 unique labels. The Delphi exercise (n=76 respondents) and face-to-face meeting (n=35 attendees) established consensus agreement for eight disease state labels and definitions. The agreed labels were as follows: asymptomatic hyperuricaemia', asymptomatic monosodium urate crystal deposition', asymptomatic hyperuricaemia with monosodium urate crystal deposition', gout', tophaceous gout', erosive gout', first gout flare' and recurrent gout flares'. There was consensus agreement that the label gout' should be restricted to current or prior clinically evident disease caused by monosodium urate crystal deposition (gout flare, chronic gouty arthritis or subcutaneous tophus). Conclusion Consensus agreement has been established for the labels and definitions of eight gout disease states, including gout' itself. The Gout, Hyperuricaemia and Crystal-Associated Disease Network recommends the use of these labels when describing disease states of gout in research and clinical practice.

Gout, Hyperuricaemia and Crystal-Associated Disease Network (G-CAN) consensus statement regarding labels and definitions of disease states of gout / D. Bursill, W.J. Taylor, R. Terkeltaub, A. Abhishek, A.K. So, A.B. Vargas-Santos, A.L. Gaffo, A. Rosenthal, A.-. Tausche, A. Reginato, B. Manger, C. Scire, C. Pineda, C. Van Durme, C.-. Lin, C. Yin, D.A. Albert, E. Biernat-Kaluza, E. Roddy, E. Pascual, F. Becce, F. Perez-Ruiz, F. Sivera, F. Liote, G. Schett, G. Nuki, G. Filippou, G. Mccarthy, G. Da Rocha Castelar Pinheiro, H.-. Ea, H.D.A. Tupinamba, H. Yamanaka, H.K. Choi, J. Mackay, J.R. Odell, J. Vazquez Mellado, J.A. Singh, J.D. Fitzgerald, L.T.H. Jacobsson, L. Joosten, L.R. Harrold, L. Stamp, M. Andres, M. Gutierrez, M. Kuwabara, M. Dehlin, M. Janssen, M. Doherty, M.S. Hershfield, M. Pillinger, N.L. Edwards, N. Schlesinger, N. Kumar, O. Slot, S. Ottaviani, P. Richette, P.A. Macmullan, P.T. Chapman, P.E. Lipsky, P. Robinson, P.P. Khanna, R.N. Gancheva, R. Grainger, R.J. Johnson, R. Te Kampe, R.T. Keenan, S.K. Tedeschi, S. Kim, S.J. Choi, T.R. Fields, T. Bardin, T. Uhlig, T. Jansen, T. Merriman, T. Pascart, T. Neogi, V. Kluck, W. Louthrenoo, N. Dalbeth. - In: ANNALS OF THE RHEUMATIC DISEASES. - ISSN 0003-4967. - 78:11(2019 Nov), pp. 1592-1600. [10.1136/annrheumdis-2019-215933]

Gout, Hyperuricaemia and Crystal-Associated Disease Network (G-CAN) consensus statement regarding labels and definitions of disease states of gout

G. Filippou;
2019

Abstract

Objective There is a lack of standardisation in the terminology used to describe gout. The aim of this project was to develop a consensus statement describing the recommended nomenclature for disease states of gout. Methods A content analysis of gout-related articles from rheumatology and general internal medicine journals published over a 5-year period identified potential disease states and the labels commonly assigned to them. Based on these findings, experts in gout were invited to participate in a Delphi exercise and face-to-face consensus meeting to reach agreement on disease state labels and definitions. Results The content analysis identified 13 unique disease states and a total of 63 unique labels. The Delphi exercise (n=76 respondents) and face-to-face meeting (n=35 attendees) established consensus agreement for eight disease state labels and definitions. The agreed labels were as follows: asymptomatic hyperuricaemia', asymptomatic monosodium urate crystal deposition', asymptomatic hyperuricaemia with monosodium urate crystal deposition', gout', tophaceous gout', erosive gout', first gout flare' and recurrent gout flares'. There was consensus agreement that the label gout' should be restricted to current or prior clinically evident disease caused by monosodium urate crystal deposition (gout flare, chronic gouty arthritis or subcutaneous tophus). Conclusion Consensus agreement has been established for the labels and definitions of eight gout disease states, including gout' itself. The Gout, Hyperuricaemia and Crystal-Associated Disease Network recommends the use of these labels when describing disease states of gout in research and clinical practice.
gout; hyperuricemia; language; monosodium urate crystals; nomenclature; terminology; urate; consensus; gout; humans; hyperuricemia; terminology as topic
Settore MED/16 - Reumatologia
nov-2019
Article (author)
File in questo prodotto:
File Dimensione Formato  
1592.full.pdf

accesso riservato

Tipologia: Publisher's version/PDF
Dimensione 697.34 kB
Formato Adobe PDF
697.34 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
064+-+G-can+terminology+in+gout.pdf

accesso riservato

Tipologia: Publisher's version/PDF
Dimensione 679.8 kB
Formato Adobe PDF
679.8 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
nihms-1595165.pdf

accesso aperto

Tipologia: Pre-print (manoscritto inviato all'editore)
Dimensione 150.99 kB
Formato Adobe PDF
150.99 kB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/1025850
Citazioni
  • ???jsp.display-item.citation.pmc??? 24
  • Scopus 70
  • ???jsp.display-item.citation.isi??? 54
social impact